artemether-lumefantrine (Coartem Dispersible)
GPTKB entity
Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:activeIngredient |
gptkb:artemether
gptkb:lumefantrine |
| gptkbp:approvedBy |
children
|
| gptkbp:ATCCode |
gptkb:P01BF01
|
| gptkbp:brand |
gptkb:artemether-lumefantrine
|
| gptkbp:form |
dispersible tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
artemether-lumefantrine (Coartem Dispersible)
|
| gptkbp:indication |
malaria
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
gptkb:Plasmodium_falciparum_malaria
|
| gptkbp:WHOModelListOfEssentialMedicines |
included
|
| gptkbp:bfsParent |
gptkb:Medicines_for_Malaria_Venture
|
| gptkbp:bfsLayer |
7
|